Orbit Resources has launched a $12 million rare earths float for its Matrix Critical Minerals spin-off, allowing the company to focus on its NSW gold-silver assets.

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

For those thinking of retirement, this six-part series provides the clarity and confidence to take the next step.

The US president’s battles with trading partners and Iran are responsible for the elevated US inflation rate – not Ukraine’s bombing of Russian oil refineries.

The ABC’s news boss is staring down the barrel of a staff revolt after threatening a senior journalist with disciplinary action.

Leonardo Maria Del Vecchio has given a wide-ranging interview as he ramped up his criticism of the leadership of his family’s company.

Flight QF6 was cancelled at the weekend and the Boeing 787 Dreamliner involved was booked for extra cleaning after passengers on an earlier flight complained of being bitten.

The sharemarket has started the week higher after banks rallied in anticipation of US earnings season.

Larvotto has hit high-grade gold and made a new discovery at its NSW Hillgrove mine, with multiple high-grade hits from the Blacklode and Midas lodes, in addition to a new lode dubbed “Echidna”.

There is plenty of blame to share and no shortage of schadenfreude at data centre player Firmus’ failure to launch. But it’s hardly a “great loss for Australia”.

Critical Resources has boots on the ground in Suriname, advancing due diligence on two gold projects as big players like Gold Fields plough capital into the region.

Drivers in Australia have not faced pump prices this high since the opening weeks of the Iran war. Things are unlikely to change until the situation is resolved.